Exploiting the pathophysiology of the gut towards innovative oral peptide delivery strategies

Project Information

NanoGut

Grant agreement ID: 850997

DOI 10.3030/850997

EC signature date 25 October 2019

Start date 1 January 2020

End date 30 June 2025

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 488 937,50

EU contribution € 1 488 937,50

Coordinated by

UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

Publications

Peer reviewed articles (2)

Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment

Author(s): Yining Xu, Herlinde De Keersmaecker, Kevin Braeckmans, Stefaan De Smedt, Patrice D. Cani, Véronique Préat, Ana Beloqui
Published in: Biomaterials, 2020, Page(s) 120209, ISSN 0142-9612
Publisher: Pergamon Press Ltd.
DOI: 10.1016/j.biomaterials.2020.120209

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment

Author(s): Valentina Marotti, Yining Xu, Cécilia Bohns Michalowski, Wunan Zhang, Inês Domingues, Hafsa Ameraoui, Tom G. Moreels, Pieter Baatsen, Matthias Van Hul, Giulio G. Muccioli, Patrice D. Cani, Mireille Alhouayek, Alessio Malfanti, and Ana Beloqui
Published in: Bioactive Materials, 2024, ISSN 2452-199X
Publisher: Elsevier
DOI: 10.1016/j.bioactmat.2023.09.014